The IVD raw materials market includes various products such as antibodies, probes, reagents and other consumables that are used for in vitro diagnostic applications. These materials are used in diagnostic tests such as immunoassays, hematology, molecular diagnostics and other types of clinical chemistry analyses. They play a vital role in producing quality and reliable test results. The increasing incidence of chronic and infectious diseases has led to higher demand for diagnostic testing, in turn fueling growth of the IVD raw materials market.
The Global IVD raw materials market is estimated to be valued at US$ 30339.66 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the IVD raw materials are Aalto Bio Reagents, Fapon Biotech, Fujirebio, Merck KgaA, F. Hoffmann-La Roche, and Thermo Fisher Scientific, among others. The major players are focusing on expanding their product portfolios as well as manufacturing facilities to cater to the growing demand.
The IVD Raw Materials Market Demand is dominated by diagnostic testing for infectious diseases, cancer, cardiac disorders and other chronic conditions. The increasing prevalence of these diseases globally will continue to drive the volume demand for diagnostic testing and subsequently the need for raw materials.
Technological developments are leading to introduction of new generation diagnostic platforms such as PCR, immunoassays, microfluidics and others that require specialized reagents and consumables. Continuous innovation is expected to widen the applications of IVD tests and fuel the need for enhanced and customized raw materials.
Market Trends
Rising healthcare expenditure in developing nations is creating new opportunities, attracting market players to target these emerging markets. Continuous research & development is helping to improve accuracy and consistency of test results through consistent composition and enhanced functional properties of raw materials.
Market Opportunities
Point-of-care and rapid diagnostics are witnessing increased adoption driven by need for faster and portable testing. This creates demand for stable and optimized raw materials suitable for decentralized settings. Growing focus on personalized medicine is also driving the need for specialized IVD components suited for particular biomarkers and genetics.
Impact of COVID-19 on IVD Raw Materials Market Growth
The COVID-19 pandemic has impacted the growth of the IVD raw materials market. In the initial phase of the pandemic, the demand for IVD raw materials saw a significant drop as IVD test manufacturing and research activities were put on halt to focus resources on COVID-19 diagnostics. The supply chain disruptions affected the availability of raw materials. However, as the pandemic intensified, the demand skyrocketed for COVID-19 testing kits, reagents, and consumables. This led to shortages in critical IVD raw materials like antibodies, enzymes, plates, and probes.
Manufacturers had to ramp up production capacities while ensuring worker safety and adopting stringent quality checks. Supply chain restructuring was done to reduce dependencies and ensure continuous raw material supply. New collaborations were formed between raw material producers and IVD kit manufacturers to cope with exponential demand. Remote working challenges had to be addressed for efficient coordination between R&D, production, and supply chain teams.
Going forward, the demand is expected to remain higher than the pre-COVID levels as focus shifts to infectious disease monitoring and research. Manufacturers will have to enhance inventory management, dual sourcing, and local sourcing strategies. Digital transformation of operations will help improve resilience. Investments in automation and quality systems will be critical for sustainably meeting future healthcare needs.
Geographical Regions with Highest IVD Raw Materials Market Value
North America has been the largest regional market for IVD raw materials in terms of value. This is driven by presence of leading global IVD product manufacturers, availability of advanced healthcare facilities, growing emphasis on early disease detection, and conducive regulatory approvals for new diagnostic technologies. The United States accounts for majority of the regional market share.
Asia Pacific region has emerged as an attractive market for IVD raw materials suppliers. Rising healthcare investments, increasing focus on infectious disease prevention, growing medical tourism, and presence of emerging economies like China and India offer lucrative growth opportunities. Rapid technology adoption and regulatory reforms are pushing the diagnostic industry transformation in Asia Pacific. The region is estimated to surpass North America as the largest IVD raw materials market in the forecast period.
Get More Insights on IVD Raw Materials Market
Discover the language that resonates with you-
About Author-
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)